Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.
Pfaff, Elke
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study. [electronic resource] - Neuro-oncology 05 2018 - 826-837 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1523-5866
10.1093/neuonc/nox216 doi
Algorithms
Biomarkers, Tumor--genetics
Brain Neoplasms--diagnosis
DNA Methylation
DNA Modification Methylases--genetics
DNA Repair Enzymes--genetics
Feasibility Studies
Female
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Glioblastoma--diagnosis
High-Throughput Nucleotide Sequencing
Humans
Male
Middle Aged
Pilot Projects
Polymorphism, Single Nucleotide
Prognosis
Promoter Regions, Genetic
Tumor Suppressor Proteins--genetics
Exome Sequencing
Whole Genome Sequencing
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study. [electronic resource] - Neuro-oncology 05 2018 - 826-837 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1523-5866
10.1093/neuonc/nox216 doi
Algorithms
Biomarkers, Tumor--genetics
Brain Neoplasms--diagnosis
DNA Methylation
DNA Modification Methylases--genetics
DNA Repair Enzymes--genetics
Feasibility Studies
Female
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Glioblastoma--diagnosis
High-Throughput Nucleotide Sequencing
Humans
Male
Middle Aged
Pilot Projects
Polymorphism, Single Nucleotide
Prognosis
Promoter Regions, Genetic
Tumor Suppressor Proteins--genetics
Exome Sequencing
Whole Genome Sequencing